Loading company
Latest annual · FY2012
Millions- Total revenues
- 27
- Operating income
- (57)
- Net income
- (54)
- Free cash flow
- (50)
Latest quarter · Q2 FY2013
Millions- Total revenues
- 1
- Operating income
- (19)
- Net income
- (20)
- Free cash flow
- (15)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2009 to FY2012
- +75.7%
Trius Therapeutics Inc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2012 | FY2011 | Change | Source |
|---|---|---|---|---|
| Revenue | $27.2 million | $41 million | -33.7% | 10-K 2013-03-13 · proof |
| Operating income | -$57.2 million | -$19.8 million | 10-K 2013-03-13 · proof | |
| Net income | -$53.9 million | -$18.3 million | 10-K 2013-03-13 · proof | |
| Cash from operating activities | -$49.5 million | -$13.2 million | 10-K 2013-03-13 · proof | |
| Free cash flow | -$50.1 million | -$14.1 million | 10-K 2013-03-13 · proof | |
| Total assets | $75.3 million | $68.1 million | +10.5% | 10-K 2013-03-13 · proof |
| Total liabilities | $18.5 million | $18.2 million | +1.4% | 10-K 2013-03-13 · proof |
| Cash and cash equivalents | $16.4 million | $11.4 million | +43.8% | 10-K 2013-03-13 · proof |
- What was Trius Therapeutics Inc's revenue in fiscal 2012?
- Trius Therapeutics Inc reported revenue of $27.2 million for fiscal 2012 (the year ended Dec 31, 2012), against $41 million the year before (-33.7%). Source: the 10-K filed with the SEC on Mar 13, 2013. SEC
- What was Trius Therapeutics Inc's operating income in fiscal 2012?
- Trius Therapeutics Inc reported operating income of -$57.2 million for fiscal 2012 (the year ended Dec 31, 2012), against -$19.8 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2013. SEC
- What was Trius Therapeutics Inc's net income in fiscal 2012?
- Trius Therapeutics Inc reported net income of -$53.9 million for fiscal 2012 (the year ended Dec 31, 2012), against -$18.3 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2013. SEC
- What was Trius Therapeutics Inc's cash from operating activities in fiscal 2012?
- Trius Therapeutics Inc reported cash from operating activities of -$49.5 million for fiscal 2012 (the year ended Dec 31, 2012), against -$13.2 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2013. SEC
- What was Trius Therapeutics Inc's free cash flow in fiscal 2012?
- Trius Therapeutics Inc reported free cash flow of -$50.1 million for fiscal 2012 (the year ended Dec 31, 2012), against -$14.1 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2013. SEC
- What are Trius Therapeutics Inc's total assets?
- As of Dec 31, 2012, Trius Therapeutics Inc reported total assets of $75.3 million, against $68.1 million a year earlier (+10.5%). Source: the 10-K filed with the SEC on Mar 13, 2013. SEC
- What are Trius Therapeutics Inc's total liabilities?
- As of Dec 31, 2012, Trius Therapeutics Inc reported total liabilities of $18.5 million, against $18.2 million a year earlier (+1.4%). Source: the 10-K filed with the SEC on Mar 13, 2013. SEC
- What are Trius Therapeutics Inc's cash and cash equivalents?
- As of Dec 31, 2012, Trius Therapeutics Inc reported cash and cash equivalents of $16.4 million, against $11.4 million a year earlier (+43.8%). Source: the 10-K filed with the SEC on Mar 13, 2013. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1356857&period_type=annual&limit=5"Information only, not investment advice.